| Quarterly Financials | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 232 | 100 | 129 | 116 | 162 | 147 | 171 | 170 | 225 |
| Expenses | 217 | 97 | 117 | 108 | 147 | 134 | 160 | 157 | 201 |
| EBITDA | 15 | 3 | 12 | 9 | 15 | 12 | 11 | 12 | 24 |
| Operating Profit % | 6 % | 2 % | 9 % | 7 % | 9 % | 8 % | 5 % | 6 % | 9 % |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 6 | 4 | 4 | 4 | 4 | 6 | 6 | 6 | 8 |
| Profit Before Tax | 9 | -2 | 8 | 4 | 10 | 5 | 4 | 5 | 16 |
| Tax | 2 | -0 | 2 | 1 | 3 | 1 | 0 | 1 | 4 |
| Net Profit | 7 | -1 | 6 | 3 | 7 | 4 | 4 | 4 | 11 |
| EPS in ₹ | 0.27 | -0.05 | 0.24 | 0.12 | 0.29 | 0.16 | 0.16 | 0.18 | 0.48 |
Sudarshan Pharma Industries
Sudarshan Pharma Industries
32.57
+1.55
(5.00%)
Market Cap
783.80 Cr
PE Ratio
31.98
Volume
1,76,000.00
Day High - Low
32.57 - 32.00
52W High-Low
35.19 - 18.50
Key Fundamentals
Market Cap
783.80 Cr
EPS
0.97
PE Ratio
31.98
PB Ratio
4.81
Book Value
6.44
EBITDA
51.32
Dividend Yield
0.00 %
Industry
Chemicals Sector
Dyes & Pigments Return on Equity
12.13
Debt to Equity
1.13
Actual
Company News
View All News
Sudarshan Pharma Industries schedules board meeting on May 22, 2026, to consider migrating equity shares from BSE SME Platform to BSE and NSE Main Boards.
Sudarshan Pharma Industries responded to BSE query, confirming board meeting on May 15, 2026 ran from 9:00 am to 9:30 am, approving USD 20M 8% FCCBs due 2029.
Sudarshan Pharma CFO Sachin Mehta Resigns
May 09, 2026
May 09, 2026Sachin Mehta steps down as CFO of Sudarshan Pharma Industries effective May 1, 2026, while continuing as Joint Managing Director. No material reasons beyond those stated.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
862.30 | #1 6,778.71 | -162.72 | #1 3,379.00 | 32.20 | 60 | -23,300.00 | 46.67 | |
393.35 | 2,360.99 | #1 0.51 | 854.90 | 14.72 | #1 265 | #1 2,739.34 | 44.11 | |
619.00 | 1,726.25 | 931.44 | 169.39 | -5.26 | 2 | -92.11 | 59.03 | |
416.35 | 1,215.74 | 14.61 | 707.10 | 23.84 | 75 | 18.34 | 48.95 | |
357.00 | 1,154.46 | 17.05 | 976.63 | 19.52 | 74 | -21.82 | 46.24 | |
68.68 | 864.98 | 28.55 | 1,756.70 | 23.76 | 19 | -96.30 | 55.40 | |
345.35 | 797.13 | 18.09 | 780.63 | -7.49 | 43 | 23.58 | 48.11 | |
32.57 | #8 783.80 | #7 31.98 | #8 703.06 | #2 38.51 | #7 23 | #2 54.05 | 67.17 | |
152.71 | 666.49 | 14.87 | 873.96 | #1 45.27 | 40 | -25.17 | 40.76 | |
195.55 | 372.65 | 66.42 | 163.10 | 8.01 | 4 | 26.67 | 49.01 |
Growth Rate
Revenue Growth
38.51 %
Net Income Growth
45.13 %
Cash Flow Change
354.45 %
ROE
18.34 %
ROCE
32.98 %
EBITDA Margin (Avg.)
-13.76 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 58 | 99 | 138 | 233 | 283 | 402 | 642 |
| Fixed Assets | 6 | 6 | 7 | 20 | 26 | 24 | 102 |
| Current Assets | 47 | 88 | 130 | 199 | 237 | 335 | 490 |
| Capital Work in Progress | 0 | 0 | 1 | 0 | 2 | 6 | 3 |
| Investments | 0 | 0 | 0 | 0 | 2 | 2 | 219 |
| Other Assets | 53 | 93 | 131 | 213 | 254 | 371 | 0 |
| Total Equity & Liabilities | 58 | 99 | 138 | 233 | 283 | 402 | 642 |
| Current Liabilities | 31 | 71 | 103 | 119 | 161 | 260 | 456 |
| Non Current Liabilities | 7 | 6 | 5 | 13 | 11 | 11 | 29 |
| Total Equity | 20 | 23 | 30 | 101 | 112 | 132 | 155 |
| Reserve & Surplus | 10 | 13 | 20 | 77 | 88 | 104 | 131 |
| Share Capital | 10 | 10 | 10 | 24 | 24 | 24 | 24 |
Cash Flow
| Cash Flow | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -2 | 0 | -1 | 12 | -12 | 0 |
| Investing Activities | -3 | -1 | -2 | -26 | -7 | -20 |
| Operating Activities | 1 | 3 | -4 | -29 | 8 | 35 |
| Financing Activities | -0 | -2 | 4 | 66 | -12 | -14 |
Share Holding
| % Holding | Mar 2023 | Sept 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 57.39 % | 57.39 % | 57.39 % | 57.39 % | 57.39 % | 57.39 % | 57.39 % | 57.39 % | 57.39 % |
| FIIs | 0.00 % | 1.40 % | 1.40 % | 13.07 % | 18.45 % | 19.48 % | 20.79 % | 19.78 % | 19.95 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.05 % | 0.05 % | 0.05 % | 0.05 % |
| Public / Retail | 20.35 % | 27.04 % | 23.61 % | 23.20 % | 18.18 % | 17.14 % | 16.30 % | 16.88 % | 16.41 % |
| Others | 22.26 % | 14.16 % | 17.59 % | 6.33 % | 5.98 % | 5.94 % | 5.46 % | 5.90 % | 6.20 % |
| No of Share Holders | 2,785 | 983 | 913 | 787 | 1,212 | 1,327 | 1,383 | 1,407 | 1,346 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.3 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.05 | 0.00 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 26 Aug 2023 |  Dividend | ₹ 0.30 /share | 25 Aug 2023 | 6.75 | 8.15 |
| 05 Feb 2024 |  Extraordinary General Meeting | NA | 05 Feb 2024 | 7.53 | 7.71 |
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 41.89 | 41.86 |
| 30 Sept 2024 | Extraordinary General Meeting | NA | 30 Sept 2024 | 21.52 | 41.86 |
| 31 Oct 2024 |  Quarterly Result Announcement | NA | 31 Oct 2024 | 35.30 | 38.48 |
| 30 Sept 2024 |  Split | 1:10 | 23 Nov 2024 | 41.86 | 41.86 |
| 04 Feb 2025 | Extraordinary General Meeting | NA | 04 Feb 2025 | 49.79 | 40.30 |
| 24 Apr 2025 | Quarterly Result Announcement | NA | 24 Apr 2025 | 29.53 | 27.81 |
| 12 Jun 2025 | Extraordinary General Meeting | NA | 12 Jun 2025 | 29.98 | 31.22 |
| 25 Jul 2025 | Annual General Meeting | NA | 25 Jul 2025 | 29.22 | 26.65 |
| 11 Aug 2025 | Extraordinary General Meeting | NA | 11 Aug 2025 | 29.20 | 30.00 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 30.00 | 30.00 |
| 18 Oct 2025 | Quarterly Result Announcement | NA | 18 Oct 2025 | 27.55 | 26.90 |
| 28 Jan 2026 | Quarterly Result Announcement | NA | 28 Jan 2026 | 19.41 | 19.23 |
| 30 Apr 2026 | Quarterly Result Announcement | NA | 30 Apr 2026 | 30.29 | 30.00 |
Announcements
Update on board meeting2 days ago
2 days agoBoard Meeting Intimation for Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Friday 22Nd May 20262 days ago
2 days agoEmail By BSE Seeking Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Announcement Dated 15/05/20262 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Investor Presentation5 days ago
5 days agoBoard Meeting Outcome for Approval Of Upto U.S. $ 20000000 Of 8.00% Senior Unsecured Foreign Currency Convertible Bonds Due 2029 Of Sudarshan Pharma Industries Limited5 days ago
5 days agoBoard Meeting Intimation for Meeting To Be Held On Friday May 15 20268 days ago
8 days agoAnnouncement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)May 08, 2026
May 08, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 04, 2026
May 04, 2026Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)May 01, 2026
May 01, 2026Announcement under Regulation 30 (LODR)-Change in ManagementApr 30, 2026
Apr 30, 2026Audited Financial Results For The Financial Year Ended 31-03-2026Apr 30, 2026
Apr 30, 2026Board Meeting Intimation for Meeting Scheduled On Thursday April 30 2026Apr 27, 2026
Apr 27, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 06, 2026
Apr 06, 2026Closure of Trading WindowMar 30, 2026
Mar 30, 2026Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Updates On GST Inspection Search And SeizureFeb 26, 2026
Feb 26, 2026Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - GST Inspection Search And SeizureFeb 22, 2026
Feb 22, 2026Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 18, 2026
Feb 18, 2026Clarification On Price Movement - Company ReplyFeb 09, 2026
Feb 09, 2026Clarification sought from Sudarshan Pharma Industries LtdFeb 09, 2026
Feb 09, 2026Announcement under Regulation 30 (LODR)-Investor PresentationJan 31, 2026
Jan 31, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 30, 2026
Jan 30, 2026Financial Results For The Quarter And Nine Months Ended 31-12-2025Jan 28, 2026
Jan 28, 2026Board Meeting Intimation for Meeting Of The Board Of Directors Scheduled To Be Held On Wednesday 28/January/2026Jan 22, 2026
Jan 22, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJan 14, 2026
Jan 14, 2026Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJan 14, 2026
Jan 14, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Jan 06, 2026Closure of Trading WindowDec 30, 2025
Dec 30, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionDec 17, 2025
Dec 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 12, 2025
Dec 12, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotDec 11, 2025
Dec 11, 2025Announcement under Regulation 30 (LODR)-Change in ManagementDec 02, 2025
Dec 02, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 20, 2025
Oct 20, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 20, 2025
Oct 20, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateOct 19, 2025
Oct 19, 2025Financial Results For The Quarter And Half Year Ended 30-Sep-2025Oct 18, 2025
Oct 18, 2025Board Meeting Intimation for Approval Of Financial Results For The Quarter And Half Year Ended 30-Sep-2025Oct 15, 2025
Oct 15, 2025Closure of Trading WindowSep 30, 2025
Sep 30, 2025Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 08, 2025
Sep 08, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionSep 08, 2025
Sep 08, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 18, 2025
Aug 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 18, 2025
Aug 18, 2025Announcement under Regulation 30 (LODR)-AcquisitionAug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Investor PresentationAug 14, 2025
Aug 14, 2025Financial Results For The Quarter 30-06-2025Aug 14, 2025
Aug 14, 2025Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportAug 12, 2025
Aug 12, 2025Shareholder Meeting / Postal Ballot-Outcome of EGMAug 12, 2025
Aug 12, 2025Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Thursday 14Th August 2025Aug 11, 2025
Aug 11, 2025Proceedings Of Extraordinary General Meeting Held On Monday 11Th August 2025Aug 11, 2025
Aug 11, 2025Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Aug 05, 2025
Aug 05, 2025Technical Indicators
RSI(14)
Neutral 60.09
ATR(14)
Volatile 1.28
STOCH(9,6)
Neutral 50.01
STOCH RSI(14)
Neutral 31.66
MACD(12,26)
Bearish -0.16
ADX(14)
Weak Trend 21.74
UO(9)
Bearish 51.23
ROC(12)
Uptrend And Accelerating 2.51
WillR(14)
Neutral -29.68
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
